Search Results - "Al Draiweesh, S"

P666 Safety of combination biologic and immunosuppressive therapy post-orthotopic liver transplantation in patients with inflammatory bowel disease: a systematic review by Al Draiweesh, S, Ma, C, Alkhattabi, M, Nguyen, T, Brahmania, M, Jairath, V

“…Abstract Background inflammatory bowel disease (IBD) patients post orthotopic liver transplantation (OLT) often have ongoing mucosal inflammation necessitating…”
Get full text

A113 TEDUGLUTIDE IN PATIENTS WITH ACTIVE CROHN’S DISEASE AND SHORT BOWEL SYNDROME by Al Draiweesh, S, Ma, C, Gregor, J C, Rahman, A, Jairath, V

“…Abstract Background Patients with Crohn’s disease (CD) are at risk of surgery due to refractory or penetrating disease, which may result in short bowel…”
Get full text

A126 SAFETY OF COMBINATION BIOLOGIC AND IMMUNOSUPPRESSIVE THERAPY POST-ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW by Al Draiweesh, S, Ma, C, Alkhattabi, M, Nguyen, T, Brahmania, M, Jairath, V

“…Abstract Background Inflammatory Bowel Disease (IBD) patients post orthotopic liver transplantation (OLT) often have ongoing mucosal inflammation necessitating…”
Get full text

DOP39 Safety of combination biologic and anti-rejection therapy post-liver transplantation in patients with inflammatory bowel disease: London Ontario experience by Al Draiweesh, S, Ma, C, Alkhattabi, M, Chande, N, Feagan, B G, Gregor, J C, Khanna, R, Marotta, P, Sandhu, A, Qumosani, K, Teriaky, A, Brahmania, M, Jairath, V

“…Abstract Background Despite anti-rejection immunosuppressive therapies post-liver transplantation (LT), patients with concurrent inflammatory bowel disease…”
Get full text

A130 SAFETY OF COMBINATION BIOLOGIC AND ANTI-REJECTION THERAPY POST-LIVER TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: LONDON ONTARIO EXPERIENCE by Al Draiweesh, S, Ma, C, Alkhattabi, M, McDonald, C, Chande, N, Feagan, B G, Gregor, J C, Khanna, R, Marotta, P, Sandhu, A S, Qumosani, K, Teriaky, A, Brahmania, M, Jairath, V

“…Abstract Background Despite anti-rejection immunosuppressive therapies post-liver transplantation (LT), patients with concurrent inflammatory bowel disease…”
Get full text